Italy
MENARINI Group is a prominent international player in the pharmaceutical and diagnostics sector, boasting a strong presence across 140 countries. With an impressive annual turnover of €4.37 billion and a workforce exceeding 17,000, the company operates on a global scale.
Renowned for its robust Research & Development capabilities across nine specialized centers, MENARINI's market offerings extend into key therapeutic areas such as cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The company's commitment to quality is evidenced by its 18 manufacturing plants, producing over 609 million product packets annually, reaching patients worldwide.
While no specific founding date, headquarter location, or investment details are provided, MENARINI's scale and international reach suggest it as a substantial entity in the pharmaceutical landscape, offering potential opportunities for investors considering stable ventures in the healthcare sector.
